Article

Analysis of Potential Biomarkers in Frontal Temporal Dementia: A Bioinformatics Approach

2023-08-09

Abstract excerpt

Frontal Temporal Dementia (FTD) is a neurological disorder known to have less therapeutic options. So far only a few biomarkers are available for FTD that can be used as potential comorbidity targets. To this end, in the present study we aim to identify potential biomarkers or susceptible genes for FTD that show comorbidities with diseases such as COVID-19 and Breast Cancer. Gene expression Omnibus datasets contai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9c888f4f-1279-5add-bcce-6ea538842742
DOI: 10.20944/preprints202308.0699.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Analysis of Potential Biomarkers in Frontal Temporal Dementia: A Bioinformatics ApproachDOI 10.20944/preprints202308.0699.v1Read

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectiveSemantic proximity Read

Identification of Molecular Signatures and Candidate Drugs in Vascular Dementia by Bioinformatics AnalysesSemantic proximity Read

Unraveling the Genetic Comorbidity Landscape of Alzheimer’s DiseaseSemantic proximity Read

Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspectiveSemantic proximity Read

Common molecular signatures between coronavirus infection and Alzheimer’s disease reveal targets for drug developmentSemantic proximity Read

Decoding the Genetic Comorbidity Network of Alzheimer's DiseaseSemantic proximity Read

Integrated multi-omics analysis reveals common and distinct dysregulated pathways for genetic subtypes of Frontotemporal DementiaSemantic proximity Read

Identification of dysregulated genes and pathways of different brain regions in Alzheimer’s diseaseSemantic proximity Read

Identification of Common Molecular Signatures Shared between Alzheimer’s and Parkinson’s Diseases and Therapeutic Agents Exploration: An Integrated Genomics ApproachSemantic proximity Read

Transcriptomic and Network Analysis Identifies Shared and Unique Pathways across Dementia Spectrum DisordersSemantic proximity Read

Detection of molecular signatures and pathways shared by Alzheimer’s disease and type 2 diabetesSemantic proximity Read

Identification of Key Pathways and Genes in Dementia via Integrated Bioinformatics AnalysisSemantic proximity Read